Anion Exchange Resins

08/01/2022 - "Anion exchange resins have been reported to be effective in patients with bile acid diarrhea after distal ileectomy; furthermore, bile acid metabolism has been implicated in the pathogenesis of CD. "
05/01/2006 - "The anion-exchange resin, cholestyramine has been reported in one small case series to be an effective treatment of severe diarrhea associated with Pfiesteria intoxication. "
06/01/1992 - "Cholestyramine is a nonabsorbable anion exchange resin that is used predominantly for the treatment of hypercholesterolemia in adults and the management of acute diarrhea in children. "

04/01/2010 - "Some treatments have proven efficacy in randomized clinical trials in patients with cholestatic disorders, such as anion exchange resins, rifampicin, opioid antagonists and ursodeoxycholic acid; the latter is especially useful in intrahepatic cholestasis of pregnancy."

01/01/1975 - "Treatment of pruritus in cholestasis of pregnancy with a new anion exchange resin (Secholex)."
04/01/1969 - "[Clinical application of anion exchange resin preparations with special reference to cases with chief complaints of itching and jaundice]."
05/01/2008 - "Two patients with PBC presented during their second trimester of pregnancy with severe pruritus that did not respond to the anion exchange resin cholestyramine. "
01/01/2000 - "Treatment at a dose of 13 to 15 mg/kg/day is optimal, given in separate doses or as a single dose at least 4 h from giving the oral anion exchange resin cholestyramine, which may be used to control pruritus. "
05/01/2019 - "Anion exchange resins, while remaining an important element in therapy, are no longer the only available medication to arrest pruritus. "

10/01/2006 - "An anion exchange resin has been reported to lower blood glucose levels in patients with type 2 diabetes. "
01/01/2011 - "We previously reported that colestimide, an anion exchange resin, improved glycemic control in patients with type 2 diabetes. "
01/01/2013 - "Colestimide, an anion exchange resin, reportedly improves glycemic control in patients with type 2 diabetes. "

08/01/2008 - "To demonstrate the safety and efficacy of this system, we used a pig model of fulminant hepatic failure (FHF) and anion exchange resin, activated charcoal and hemodialysis for the purification device. "